Product Description
Overall, the global interventional coronary guidewire market was valued at over $420 million in 2022. This is expected to increase over the forecast period at a CAGR of 1.8% to reach over $475 million.
The full report suite includes the coronary guidewire market. Coronary guidewires are used to deliver therapies to diseased areas of the coronary arterial system.
Market Data Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Global Procedure Numbers by Region
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Interventional Coronary Guidewire Market Analysis
Unfavorable reimbursement conditions for coronary guidewires are expected to lead to bundled contracts and cost-saving measures in hospitals and labs, fueling competition and gradual price growth in the global market. Additionally, the adoption of specialty guidewires for chronic total occlusion (CTO) crossing and the emergence of newer devices for challenging lesions have the potential to drive growth in the interventional coronary guidewire market and the overall interventional cardiology device market. Moreover, advancements in pre-surgery imaging are likely to contribute to a decline in the number of guidewires required per procedure over the forecast period.
Global Interventional Coronary Guidewire Market Share Analysis
Abbott, the leading competitor in the interventional coronary guidewire market, has established itself as a prominent player in the industry. The company’s success can be attributed to its innovative offerings, including the Hi-Torque™ device based on the acquired Guidant technology and the Asahi family of coronary guidewires, licensed from Asahi Intecc. Abbott’s collaboration with Asahi Intecc has further strengthened its product portfolio. Asahi Intecc is renowned for its expertise in guidewire manufacturing, and the licensed Asahi family of coronary guidewires complements Abbott’s offerings. These guidewires are known for their high-quality construction, flexibility, and navigational capabilities, contributing to successful interventional procedures. Boston Scientific follows with a diverse range of guidewires including ChoICE™, Forté™, Luge™, Magic Torque™, Meier™, Mailman™, Platinum Plus™, PT Graphix™, PT²™, SAFARI2™, and SENTAI™ lines, leveraging brand recognition and extensive networks to expand market share. Biotronik ranks third, manufacturing a variety of guidewires including Magnum® with enhanced crossability and Cruiser® enabling multivessel treatment, particularly popular in Germany.
Research Regional Coverage
Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis of a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled Global Market Report Suite for Interventional Cardiology – MedSuite
